secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alector, Inc. (ALEC)
CIK:        0001653087
Form:       8-K
Filed at:   2022-07-07T23:59:59+00:00
Accession:  0001193125-22-189463
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

AbbVie terminates Alector's AL003/CD33 Alzheimer's collaboration
----------------------------------------------------------------

- AbbVie provided written notice on June 30, 2022 terminating the CD33 (AL003) program.
- Alector and AbbVie continue to advance the AL002 (TREM2) program under the existing agreement.
- No financial or milestone termination payments disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1653087/000119312522189463/0001193125-22-189463-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1653087/000119312522189463/d317537d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-189463

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer